Indications and uses
For flushing the eye and skin to reduce chances of severe injury caused by acid, alkali, or particulate contamination.
For flushing the eye and skin to reduce chances of severe injury caused by acid, alkali, or particulate contamination.
● do not dilute solution or reuse bottle ● to open, twist cap in the direction of the arrow ● center the DUO between the eyes to simultaneously wash both eyes ● control flow of solution by pressure on bottle ● flush affected area as needed ● continue to flush with water as necessary ● obtain medical treatment
Purified water 95.1%
Emergency eyewash and skin flush
For flushing the eye and skin to reduce chances of severe injury caused by acid, alkali, or particulate contamination.
● for injection ● in intraocular surgery ● internally
● If solution changes color or becomes cloudy
● avoid contamination ● do not reuse
Once opened, discard.
● eye pain ● changes in vision
● redness or irritation of the eye after use ● an injury caused by alkali
If swallowed, get medical help or contact a Poison Control Center right away.
● do not dilute solution or reuse bottle
● to open, twist cap in the direction of the arrow
● center the DUO between the eyes to simultaneously wash both eyes
● control flow of solution by pressure on bottle ● flush affected area as needed
● continue to flush with water as necessary ● obtain medical treatment
● not for use as a contact lens solution ● twist cap to open
● use before expiration date marked on bottle
● store at room temperature 5° to 35° C (41° to 95°F)
Sodium phosphate dibasic, Monopotassium phosphate
Questions or Comments? Call toll-free number 1-800-423-5278
Bel-Art Products ● 661 Route 23 South ● Wayne, NJ 07470
Plum
EMERGENCY EYEWASH
pH NEUTRALIZING
NDC 67691-201-22
DUO
STERILE
500 ml (16.9 fl oz)
Bel-Art Products
661 Route 23 South, New Jersey, 07470
Tel: 973-694-0500 Fax: 973-694-7199
www.belart.com
Compliance: ANSI/ISEA Z358.1-2009
(As a Personal Eyewash Only)
Duo pH Neutralizer Label r1.jpg
Duo pH Neutralizer Label r1.jpg
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 67691-201-22 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-01d2-f424-e053-dadaa90a57ce | Plum Emergency Eyewash pH Neutralizing Duo |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Water | ACTIVE INGREDIENT | 059QF0KO0R | 4 | |
| Water | ACTIVE MOIETY | 059QF0KO0R | 4 | |
| Potassium Phosphate, Monobasic | INACTIVE INGREDIENT | 4J9FJ0HL51 | 4 | |
| Sodium Phosphate, Dibasic | INACTIVE INGREDIENT | GR686LBA74 | 4 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 67691-201 | 67691-201-22 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Water | 059QF0KO0R | ACTIB |
| Sodium Phosphate, Dibasic | GR686LBA74 | IACT |
| Potassium Phosphate, Monobasic | 4J9FJ0HL51 | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Sodium Phosphate, Dibasic | SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | INJECTION / INTRADERMAL | 0.2 %w/v | ||
| Potassium Phosphate, Monobasic | MONOBASIC POTASSIUM PHOSPHATE | 4J9FJ0HL51 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 110 mg | ||
| Sodium Phosphate, Dibasic | SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 40 mg | ||
| Potassium Phosphate, Monobasic | MONOBASIC POTASSIUM PHOSPHATE | 4J9FJ0HL51 | SOLUTION / ORAL | 287 mg | ||
| Potassium Phosphate, Monobasic | MONOBASIC POTASSIUM PHOSPHATE | 4J9FJ0HL51 | CAPSULE, DELAYED RELEASE PELLETS / ORAL | 272 mg | ||
| Sodium Phosphate, Dibasic | SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | TABLET, EXTENDED RELEASE / ORAL | 143 mg | ||
| Sodium Phosphate, Dibasic | SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | INJECTION / SUBCUTANEOUS | 14 mg | ||
| Sodium Phosphate, Dibasic | SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | FILM, SOLUBLE / ORAL | 9 mg | ||
| Sodium Phosphate, Dibasic | SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | 2.98 mg | ||
| Sodium Phosphate, Dibasic | SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | SOLUTION / ORAL | 40 mg/1ml | ||
| Potassium Phosphate, Monobasic | MONOBASIC POTASSIUM PHOSPHATE | 4J9FJ0HL51 | SPRAY / NASAL | 3 mg | ||
| Sodium Phosphate, Dibasic | SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | INJECTION / INTRAVENOUS | 200 mg | ||
| Sodium Phosphate, Dibasic | SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | SYRUP / ORAL | 70 mg | ||
| Potassium Phosphate, Monobasic | MONOBASIC POTASSIUM PHOSPHATE | 4J9FJ0HL51 | TABLET, EXTENDED RELEASE / ORAL | 4 mg | ||
| Potassium Phosphate, Monobasic | MONOBASIC POTASSIUM PHOSPHATE | 4J9FJ0HL51 | SOLUTION / AURICULAR (OTIC) | 0.2 %w/w | ||
| Potassium Phosphate, Monobasic | MONOBASIC POTASSIUM PHOSPHATE | 4J9FJ0HL51 | INJECTION / INTRAVENOUS | 68 mg | ||
| Potassium Phosphate, Monobasic | MONOBASIC POTASSIUM PHOSPHATE | 4J9FJ0HL51 | SOLUTION / NASAL | 680 mg | ||
| Potassium Phosphate, Monobasic | MONOBASIC POTASSIUM PHOSPHATE | 4J9FJ0HL51 | INJECTION, SOLUTION / INTRAVESICAL | 29.2 mg | ||
| Potassium Phosphate, Monobasic | MONOBASIC POTASSIUM PHOSPHATE | 4J9FJ0HL51 | SYRUP / ORAL | 19 mg | ||
| Potassium Phosphate, Monobasic | MONOBASIC POTASSIUM PHOSPHATE | 4J9FJ0HL51 | INJECTION / INTRA-ARTICULAR | 0.3 %w/v | ||
| Sodium Phosphate, Dibasic | SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | SUSPENSION / OPHTHALMIC | 0.43 %w/w | ||
| Potassium Phosphate, Monobasic | MONOBASIC POTASSIUM PHOSPHATE | 4J9FJ0HL51 | SUSPENSION / ORAL | 50 mg/5ml | ||
| Potassium Phosphate, Monobasic | MONOBASIC POTASSIUM PHOSPHATE | 4J9FJ0HL51 | INJECTION / SUBCUTANEOUS | 8 mg | ||
| Potassium Phosphate, Monobasic | MONOBASIC POTASSIUM PHOSPHATE | 4J9FJ0HL51 | INJECTION, SOLUTION / INTRAVENOUS | 1.36 %w/v | ||
| Potassium Phosphate, Monobasic | MONOBASIC POTASSIUM PHOSPHATE | 4J9FJ0HL51 | INJECTION / INTRAMUSCULAR | 0.3 %w/v | ||
| Sodium Phosphate, Dibasic | SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 40 mg | ||
| Sodium Phosphate, Dibasic | SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | CONCENTRATE / ORAL | 17 mg/5ml | ||
| Potassium Phosphate, Monobasic | MONOBASIC POTASSIUM PHOSPHATE | 4J9FJ0HL51 | SUSPENSION / OPHTHALMIC | 0.44 %w/w | ||
| Sodium Phosphate, Dibasic | SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | INJECTION / INTRAMUSCULAR | 40 mg | ||
| Potassium Phosphate, Monobasic | MONOBASIC POTASSIUM PHOSPHATE | 4J9FJ0HL51 | CAPSULE, COATED PELLETS / ORAL | 272 mg | ||
| Potassium Phosphate, Monobasic | MONOBASIC POTASSIUM PHOSPHATE | 4J9FJ0HL51 | TABLET / ORAL | 25 mg | ||
| Potassium Phosphate, Monobasic | MONOBASIC POTASSIUM PHOSPHATE | 4J9FJ0HL51 | SOLUTION / OPHTHALMIC | 0.2 %w/w | ||
| Sodium Phosphate, Dibasic | SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | CREAM / TOPICAL | 0.1 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 78acd337-53d8-40d9-bdaf-dc7fdf23f2f0 | 4ae2048a-940a-48a2-afff-71b40a5d35a1 | 2015-01-20 | Warnings | 78acd337-53d8-40d9-bdaf-dc7fdf23f2f0 4ae2048a-940a-48a2-afff-71b40a5d35a1 |
Adverse event summaries are temporarily unavailable. Other product information remains available.